UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report: October 3, 2011
CREENERGY CORPORATION
----------------------------
(Exact name of registrant as specified in its charter)
Nevada 333-133347 98-0479983
---------------------------- ------------------ ----------------------
(State or other jurisdiction (Commission File (IRS Employer Identifi
of incorporation) Number) -cation Number)
601 Union Street, Two Union Square, 42nd Floor, Seattle, Washington 98101
-------------------------------------------------------------------------
(Address of Principal Executive Offices) (Zip Code)
(206) 388-5498
------------------
Registrant's telephone number, including area code
Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any of the
following provisions:
[ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange
Act (17 CFR 240.14d-2(b))
[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange
Act (17 CFR 240.13e-4(c))
SECTION 5 - CORPORATE GOVERNANCE AND MANAGEMENT
Item 5.02 Departure of Directors or Certain Officers; Election of Directors;
Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
Resignation of Officers
Effective October 3, 2011, Shari Sookarookoff has resigned from her position as
President and Chief Executive Officer and as Secretary/Treasurer and Chief
Financial Officer of CreeEnergy, Inc. ("the Company.")
Appointment of Officers & Directors
Effective October 3, 2011, Dr. William Campbell, Ph.D. has been appointed as
Chief Scientific Officer and a Director of the Company.
Effective October 3, 2011, Dr. Scott McKinley, Ph.D. has been appointed as
Chairman of the Board of Directors and Chief Operating Officer of the Company.
Effective October 3, 2011, Ms. Deborah Fortescue-Merrin, has been appointed as
the President of the Company and Mr. Richard Fortescue, brother of Ms. Deborah
Fortescue-Merrin, has been appointed as Chief Financial Officer for the Company.
Their biographies are as follows.
Dr. William Campbell, Ph.D., B.Sc., M.Sc., Ph.D., 70, Director, Chief Scientific
Officer
Dr. Campbell completed his B.Sc. in Chemistry at Concordia University (1962) and
obtained his PhD in Microbiology and Immunology from the University of Montreal
(1971). Dr. Campbell has over 35 year of experience in the field of protein
chemistry in Canada and Japan. He was senior researcher at the Choju Institute
in Toyohashi, Japan, and Associate Professor at Nagoya City University in Japan
from 1987 through 2002. He was scientific editor of the journal of Microbiology
and Immunology. Dr. Campbell has also been the visiting scientist at the Kinsmen
Laboratory of Neurological Research at the University of British Columbia. Since
2007 he has run Biomime Solutions, a consulting company based in Richmond, BC,
and does contract work with University of British Columbia and several biotech
companies. He is Chairman of the Board of Directors at Kinexus Bioinformatics in
Vancouver, since 2007.
Dr. Scott McKinley, B.Sc., M.Sc., Ph.D., 57, Chairman of the Board of Directors,
Chief Operating Officer
Dr. McKinley received his Ph.D. from the University of Waterloo, 1993. He has
mentored and supervised the research of dozens of graduate students and
postdoctoral fellows. He has also been the recipient of two Research Chairs: a)
Natural Sciences and Engineering Research Council ("NSERC") /Industrial Research
Chair and b) Canada Research Chair (Tier 1). Dr. McKinley holds a number of
directorships including the Vancouver Aquarium, Centre for Aquaculture and
Environmental Research (a partnership between UBC and Department of Fisheries
and Oceans ["DFO"]), and Pacific Ocean Shelf Tracking ("POST"). Dr. McKinley was
recently appointed to be a member of the High Level Expert Forum on how to feed
the world population in 2050, sponsored by the Food and Agriculture Organization
of the United Nations.
Dr. McKinley is currently a Professor of Animal Science at University of British
Columbia, since 2001. He has over 30 years of experience in the field of
ecology, animal physiology and biochemistry. He has conducted his research
across Canada and Europe in fresh and marine waters. He has held a senior Canada
Research Chair and an Industrial and Natural Sciences and Engineering Chair and
has author two patents. He has served as Chair of the Technical Board of Experts
for the Great Lakes Fishery Commission, Research committee for the Pacific Ocean
Shelf Tracking (POST) study, and a member of the Board of Directors for POST and
the Vancouver Aquarium. He is presently Director of the West Vancouver Marine
Laboratory.
Deborah Fortescue-Merrin, 55, President
Ms. Deborah Fortescue-Merrin, B.Sc. (Biology/Human Genetics) from the University
of British Columbia, 1977, has been a director and officer of numerous publicly
traded companies over the past 15 years. She completed the IDA Registered
Representative Securities Course in 1981, and was an investment advisor for
twelve years, ultimately working in the area of corporate finance, specializing
in special situations concerning medical issues. Ms. Fortescue-Merrin also
delivered the daily C.M. Oliver market reports on CHQM radio in Vancouver from
1982-1984. She has lectured at a number of international anti-aging medicine
congresses on the topic of Mandelic Acid in Dermatology. She has been the
President, C.E.O., and director of North American Medical Services Inc., (NMI.V
- TSX-V), NuCelle Inc. (wholly owned subsidiary of NMI), since 2001, and Creator
Capital Limited (CTORF-OTCBB) since 1999.
Richard Fortescue, 58, Chief Financial Officer
Mr. Richard Fortescue, B.Comm. graduated from the University of British Columbia
in 1976. He has been the C.F.O. of North American Medical Services Inc. (NMI.V -
TSX-V), NuCelle Inc. (wholly owned subsidiary of NMI), since 2009, and Director
of Administrative Affairs for Creator Capital Limited (CTORF-OTCBB) since 2001.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934,
the Registrant has duly caused this Report to be signed on its behalf by the
undersigned, hereunto duly authorized.
CREENERGY CORPORATION
By: /s/ Deborah Fortescue-Merrin
--------------------------------------
Deborah Fortescue-Merrin
Date: October 3, 2011
